← Eichor
Study identifier: NCT06191159 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Cosmetic Outcome of Electrocautery, Scalpel and PEAK PlasmaBlade for Surgical Breast Incisions

Condition: Wound Complication · Surgical Wound Infection · Post-operative Pain  ·  Sponsor: University of British Columbia

PhaseNA
Planned participants186
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

This study will compare the cosmetic scar result from the use of scalpel, electrocautery, and pulsed electron avalanche knife (PEAK) PlasmaBlade (PPB) for the initial skin incision for total mastectomy procedures without immediate breast reconstruction. It is hypothesized that there will be no significant difference in mastectomy scar cosmesis. The purpose and objectives of this study are: 1. To evaluate and compare the cosmetic scar result from the use of scalpel, standard electrocautery, or PEAK PlasmaBlade for initial incision for total mastectomy procedures without immediate breast reconstruction. 2. To inform future equipment choices for breast surgery including potential elimination of scalpels and their attendant risks.

This description comes directly from the study's public registry record.

Talk to the study team

Carol K Dingee, MD, FRCSC  ·  6048741141  ·  cdingee2@providencehealth.bc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Mount Saint Joseph HospitalVancouver, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06191159